Risk factors for systemic reactions to allergen immunotherapy.
作者： Alfredo Iglesias-Cadarso , Pilar Hernández-Weigand
DOI: 10.1097/ACI.0B013E32834C229E
关键词: Systemic reaction 、 Intensive care medicine 、 Medicine 、 Immunotherapy 、 Product (category theory) 、 Allergen immunotherapy 、 Clinical Practice
摘要: Purpose of reviewTo update safety information regarding allergen-specific immunotherapy (ASIT) in clinical practice and highlight the risk factors associated with adverse reactions, product each dose.Recent findingsEfforts recent years have focused on increasing our understanding e
sci-hub.se 参考文章(61)
U. S. Petersen, F. Madsen, A. Frost, L. Frølund, M. Christensen, Quality assurance ofallergen-specific immunotherapy during a national outbreak of anaphylaxis: results of a continuous sentinel event surveillance system. Journal of Investigational Allergology and Clinical Immunology. ,vol. 19, pp. 253- 259 ,(2009)
S. Echechipía, B. E. García, M. T. Lizaso, J. M. Olaguibel, A. I. Tabar, A. Rodríguez, Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma. Journal of Investigational Allergology and Clinical Immunology. ,vol. 10, pp. 327- 333 ,(2000)
P. Demoly, N. Soohun, S. Caimmi, C. Gallen, N. Zankar, Céline Galera, Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab. Journal of Investigational Allergology and Clinical Immunology. ,vol. 19, pp. 225- 229 ,(2009)
Jean Bousquet, HJ Schünemann, PJ Bousquet, Claus Bachert, GW Canonica, TB Casale, P Demoly, S Durham, K‐H Carlsen, H‐J Malling, Giovanni Passalacqua, FER Simons, J Anto, CE Baena‐Cagnani, K‐C Bergmann, T Bieber, AH Briggs, J Brozek, MA Calderon, R Dahl, P Devillier, R Gerth van Wijk, P Howarth, D Larenas, NG Papadopoulos, P Schmid‐Grendelmeier, Torsten Zuberbier, None, How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy. ,vol. 66, pp. 765- 774 ,(2011) , 10.1111/J.1398-9995.2011.02590.X
S. Radulovic, D. Wilson, M. Calderon, S. Durham, Systematic reviews of sublingual immunotherapy (SLIT) Allergy. ,vol. 66, pp. 740- 752 ,(2011) , 10.1111/J.1398-9995.2011.02583.X
Sigrid Payne DaVeiga, Xiaobo Liu, Kathleen Caruso, Susan Golubski, Meng Xu, David M. Lang, Systemic reactions associated with subcutaneous allergen immunotherapy: timing and risk assessment. Annals of Allergy Asthma & Immunology. ,vol. 106, pp. 533- 537 ,(2011) , 10.1016/J.ANAI.2011.02.007
Lucyna Gorska, Marta Chelminska, Krzysztof Kuziemski, Marcin Skrzypski, Marek Niedoszytko, Iwona Damps-Konstanska, Amelia Szymanowska, Alicja Siemińska, Beata Wajda, Adrianna Drozdowska, Marek Jutel, Ewa Jassem, Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy. International Archives of Allergy and Immunology. ,vol. 147, pp. 241- 245 ,(2008) , 10.1159/000142048
L. Businco, L. Zannino, A. Cantani, A. Corrias, A. Fiocchi, M. La Rosa, Systemic reactions to specific immunotherapy in children with respiratory allergy: a prospective study. Pediatric Allergy and Immunology. ,vol. 6, pp. 44- 47 ,(1995) , 10.1111/J.1399-3038.1995.TB00257.X
Michael Blaiss, Jennifer Maloney, Hendrik Nolte, Sandra Gawchik, Ruji Yao, David P. Skoner, Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents The Journal of Allergy and Clinical Immunology. ,vol. 127, pp. 64- 71 ,(2011) , 10.1016/J.JACI.2010.11.034
R LOCKEY, P TURKELTAUB, E OLIVE, J HUBBARD, I BAIRDWARREN, S BUKANTZ, The Hymenoptera venom study III: Safety of venom immunotherapy2 Journal of Allergy and Clinical Immunology. ,vol. 86, pp. 775- 780 ,(1990) , 10.1016/S0091-6749(05)80182-4